Mergers & Acquisitions

ExsoMed, whose products support an intermedullary approach to treat hand fractures, enhances Acumed’s portfolio of upper extremity solutions for simple...

The amended agreement reduces the closing payment to $50 million (plus $50 million deposited into escrow last year) from the...

Onkos is expanding its musculoskeletal oncology portfolio with the JTS device to treat pediatric bone cancer....

In2Bones' product portfolio includes implants, fracture systems, biologics and related hardware to treat upper and lower extremities....

The move allows Medartis to further accelerate its U.S. extremities business....

ORHub will enter the medical device market with biologics to regenerate cartilage and address degenerative disc disease and osteoarthritis....

The move will expand Isto's portfolio of procedure-specific allografts for spine, orthopedic and sports medicine applications....

The move expands OrthoPediatrics' portfolio with a patented, non-operative solution for the treatment of clubfoot....

The decision follows FDA's recent premarket approval of CartiHeal’s Agili-C implant for the treatment of osteoarthritis....